These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 16508724)
61. Letter to the editor in response to "Stage 1, grade 3 endometrioid adenocarcinoma of the endometrium: An analysis of clinical outcomes and patterns of recurrence". Pollock J Gynecol Oncol; 2010 Jun; 117(3):507; author reply 507-8. PubMed ID: 20189231 [No Abstract] [Full Text] [Related]
63. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors. Ritterhouse LL; Howitt BE Surg Pathol Clin; 2016 Sep; 9(3):405-26. PubMed ID: 27523969 [TBL] [Abstract][Full Text] [Related]
64. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators. An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071 [TBL] [Abstract][Full Text] [Related]
65. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Lax SF; Kurman RJ Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874 [TBL] [Abstract][Full Text] [Related]
67. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival. DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575 [TBL] [Abstract][Full Text] [Related]
68. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321 [TBL] [Abstract][Full Text] [Related]
69. Microsatellite instability analysis in uterine cavity washings as a screening tool for endometrial cancer in Lynch syndrome. Bouquier J; Blons H; Narjoz C; Lécuru F; Laurent-Puig P; Bats AS Fam Cancer; 2011 Dec; 10(4):655-7. PubMed ID: 21822721 [TBL] [Abstract][Full Text] [Related]
70. MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma. Sato K; Miyamoto M; Takano M; Tsuda H Virchows Arch; 2021 Nov; 479(5):883-891. PubMed ID: 34331128 [TBL] [Abstract][Full Text] [Related]
71. Endometrial adenocarcinoma: a primer for the generalist. Hernandez E Obstet Gynecol Clin North Am; 2001 Dec; 28(4):743-57. PubMed ID: 11766149 [TBL] [Abstract][Full Text] [Related]
72. Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case. Gizzo S; Fabris A; Litta P; Saccardi C Int J Clin Exp Pathol; 2014; 7(5):2664-9. PubMed ID: 24966983 [TBL] [Abstract][Full Text] [Related]